Meltwind Advisory
Meltwind Advisory LLP is an advisory and investment firm based in Cambridge, UK. Founded by Jonathan Milner, the former CEO of Abcam, the firm specializes in supporting early-stage healthcare and biotechnology companies. Meltwind focuses on due diligence and portfolio management for investments, particularly in Series A and Series B life science tools and platform therapeutics. The firm provides strategic investment guidance and support across various sectors, including drug discovery, medical devices, cell therapy, research tools, synthetic biology, digital health, wound healing, aging, and
Investing activity
Meltwind Advisory appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $16M. The rounds are mostly Seed, with a median round size of $16M. The most recent is Syndex Bio (Seed, $15.5M, Feb 2026).
Meltwind Advisory most often invests alongside Arch Venture Partners, +ND Capital and OMX Ventures, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Meltwind Advisory
What AI companies has Meltwind Advisory invested in?
Meltwind Advisory's AI investments include Syndex Bio. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Meltwind Advisory based?
Meltwind Advisory is based in Cambridge, England, United Kingdom.
What stage does Meltwind Advisory invest at?
In the rounds tracked on AI Lounge, Meltwind Advisory has invested at Seed, with a median round of $16M.
Who does Meltwind Advisory co-invest with?
Meltwind Advisory's most frequent co-investors on AI Lounge are Arch Venture Partners (1 deal), +ND Capital (1 deal) and OMX Ventures (1 deal).
How can founders reach Meltwind Advisory?
Founders on AI Lounge can see Meltwind Advisory's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Meltwind Advisory to their Investor Pipeline to track the conversation.